-
1
-
-
0018037502
-
Characterization of mononuclear cell infiltrates in psoriatic lesions
-
Bjerke JR, Krogh HK, Matre R. Characterization of mononuclear cell infiltrates in psoriatic lesions. J Invest Dermatol. 1978;71:340-343.
-
(1978)
J Invest Dermatol
, vol.71
, pp. 340-343
-
-
Bjerke, J.R.1
Krogh, H.K.2
Matre, R.3
-
2
-
-
0020595264
-
Immunocompetent cells in psoriasis: In situ immunophenotyping by monoclonal antibodies
-
Bos JD, Hulsebosch HJ, Krieg SR, et al. Immunocompetent cells in psoriasis: in situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res. 1983;275:181-189.
-
(1983)
Arch Dermatol Res
, vol.275
, pp. 181-189
-
-
Bos, J.D.1
Hulsebosch, H.J.2
Krieg, S.R.3
-
3
-
-
0030942048
-
Lymphocyte activation in health and disease
-
Berridge MJ. Lymphocyte activation in health and disease. Crit Rev Immunol. 1997;17:155-178.
-
(1997)
Crit Rev Immunol
, vol.17
, pp. 155-178
-
-
Berridge, M.J.1
-
4
-
-
1542358942
-
Rituximab: Expanding role in therapy for lymphomas and autoimmune diseases
-
Rastetter W, Molina A, White CA. Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med. 2004;55:477-503.
-
(2004)
Annu Rev Med
, vol.55
, pp. 477-503
-
-
Rastetter, W.1
Molina, A.2
White, C.A.3
-
5
-
-
0142218537
-
B cell therapy for rheumatoid arthritis: The rituximab (anti-CD20) experience
-
Shaw T, Quan J, Totoritis MC. B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience. Ann Rheum Dis. 2003;62(suppl 2):ii55-59.
-
(2003)
Ann Rheum Dis
, vol.62
, Issue.2 SUPPL.
-
-
Shaw, T.1
Quan, J.2
Totoritis, M.C.3
-
6
-
-
0027998659
-
Immunohistochemical markers for arthritis in psoriasis
-
Veale DJ, Barnes L, Rogers S, et al. Immunohistochemical markers for arthritis in psoriasis. Ann Rheum Dis. 1994;53:450-454.
-
(1994)
Ann Rheum Dis
, vol.53
, pp. 450-454
-
-
Veale, D.J.1
Barnes, L.2
Rogers, S.3
-
7
-
-
0032794614
-
Elevated B-lymphocyte levels in lesional tissue of non-arthritic psoriasis
-
Mahmoud F, Abul H, al Saleh Q, et al. Elevated B-lymphocyte levels in lesional tissue of non-arthritic psoriasis. J Dermatol. 1999;26:428-433.
-
(1999)
J Dermatol
, vol.26
, pp. 428-433
-
-
Mahmoud, F.1
Abul, H.2
Al Saleh, Q.3
-
8
-
-
0032697669
-
Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma
-
Protheroe A, Edwards JCW, Simmons A, et al. Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology (Oxford). 1999;38:1150-1152.
-
(1999)
Rheumatology (Oxford)
, vol.38
, pp. 1150-1152
-
-
Protheroe, A.1
Edwards, J.C.W.2
Simmons, A.3
-
9
-
-
0037259007
-
Biologic therapy for psoriasis: The tumor necrosis factor inhibitors infliximab and etanercept
-
Weinberg JM, Saini R. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept. Cutis. 2003;71:25-29.
-
(2003)
Cutis
, vol.71
, pp. 25-29
-
-
Weinberg, J.M.1
Saini, R.2
-
10
-
-
0346958302
-
A new era in rheumatoid arthritis treatment
-
Costello JC, Halverson PB. A new era in rheumatoid arthritis treatment. WMJ. 2003;102:29-33.
-
(2003)
WMJ
, vol.102
, pp. 29-33
-
-
Costello, J.C.1
Halverson, P.B.2
-
11
-
-
0031692017
-
CD20-positive T-cell chronic lymphocytic leukaemia
-
Takami A, Saito M, Nakao S, et al. CD20-positive T-cell chronic lymphocytic leukaemia. Br J Haematol. 1998;102:1327-1329.
-
(1998)
Br J Haematol
, vol.102
, pp. 1327-1329
-
-
Takami, A.1
Saito, M.2
Nakao, S.3
|